Barbara Bailus, PhD

"I was first introduced to Angelman syndrome when doing my doctoral research in Dr. Segal's lab. My connection continued with the Angelman community as a scientific advisor and volunteer during my postdoctoral studies, and continues now as I do Angelman research in my own laboratory."

Dr. Barbara Bailus is an Assistant Professor of Genetics at The Keck Graduate Institute, of the Claremont Colleges. She did her doctoral research at University of California, Davis in the Segal Laboratory developing a gene therapy based on artificial transcription factors for the treatment of Angelman syndrome. Her postdoctoral research was in the Ellerby Lab at The Buck Institute for Research on Aging, focused on neurodegenerative disorders. In 2021 Dr. Bailus was honored to take on the role of Chair of the Scientific Advisory Board for the Foundation for Angelman Syndrome Therapeutics (FAST).The Bailus Lab focuses on novel delivery mechanisms and treatments for neurological disorders, including Angelman syndrome. Dr. Bailus has a passion for teaching the next generation of scientists and communicating exciting scientific advances to the public. When not in the lab or classroom she enjoys being outside, traveling, riding horses, and painting.

Scientific Advisory Board • Board Chair

Keck Graduate Institute | Claremont, CA

Scientific Advisory Board • Board Chair image

Notable Publications:

  • Protein Delivery of Artificial Transcription Factor Restores Widespread Ube3a Expression in an Angelman Syndrome Mouse Brain

  • The Prospect of molecular therapy for Angelman syndrome and other monogenic neurologic disorders

  • Modulating FKBP5/FKBP51 and autophagy lowers HTT (huntingtin) levels

Contact Dr. Bailus:

FAST Global Science Summit Presentations

Angelman Syndrome News